|
TYW1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.636200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.030000E-01 |
| Normal-vs-Stage2 |
2.817200E-01 |
| Normal-vs-Stage3 |
5.736800E-01 |
| Normal-vs-Stage4 |
3.830800E-01 |
| Stage1-vs-Stage2 |
5.998600E-01 |
| Stage1-vs-Stage3 |
7.394400E-01 |
| Stage1-vs-Stage4 |
9.266200E-01 |
| Stage2-vs-Stage3 |
5.290600E-01 |
| Stage2-vs-Stage4 |
7.189800E-01 |
| Stage3-vs-Stage4 |
7.512800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.440000E-01 |
| Normal-vs-AfricanAmerican |
9.086200E-01 |
| Normal-vs-Asian |
6.229600E-01 |
| Caucasian-vs-AfricanAmerican |
3.846800E-01 |
| Caucasian-vs-Asian |
9.476000E-01 |
| AfricanAmerican-vs-Asian |
6.846600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.440600E-01 |
| Normal-vs-Female |
2.625600E-01 |
| Male-vs-Female |
7.067000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.763800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.118600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.683780E-01 |
| Normal-vs-Age(81-100Yrs) |
8.458200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.391200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.372200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.795400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.014200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.087400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.961200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.148800E-01 |
| Normal-vs-Grade 2 |
3.899800E-01 |
| Normal-vs-Grade 3 |
9.957600E-02 |
| Normal-vs-Grade 4 |
8.251400E-01 |
| Grade 1-vs-Grade 2 |
9.519600E-01 |
| Grade 1-vs-Grade 3 |
5.346200E-01 |
| Grade 1-vs-Grade 4 |
5.833200E-01 |
| Grade 2-vs-Grade 3 |
3.076600E-01 |
| Grade 2-vs-Grade 4 |
3.227200E-01 |
| Grade 3-vs-Grade 4 |
1.101970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.779600E-02 |
| Normal-vs-ccB subtype |
4.256600E-01 |
| ccA subtype-vs-ccB subtype |
3.167000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.778000E-02 |
| Normal-vs-N1 |
5.675000E-01 |
| N0-vs-N1 |
9.571400E-01 |
|
|
